USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Dec 2, 2021 (est) | Sep 30, 2021 | - | $-0.78 | $-0.02 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Dec 2, 2021 (est) | Sep 30, 2021 | - | $412.47M | - |
Clover Health Investments's next estimated earnings date (based on same quarter last year's date) is Dec 2, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.33 | $-0.60 | $-0.13 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-1.52 | $-2.22 | $-0.98 |
| Dec 2022 | 4 | $-1.01 | $-2.46 | $-0.15 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.33 | $-0.18 | $-0.12 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.50 | $-0.81 | $-0.51 |
| Dec 2022 | 0 / 0 | $-0.95 | $-0.40 | $-0.33 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $413.45M | $404.26M | $421.53M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $1.44B | $1.43B | $1.45B |
| Dec 2022 | 4 | $2.71B | $2.34B | $3.05B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 11, 2021 | Jun 2021 | $-0.14 | $-0.78 | -472.69% |
| May 17, 2021 | Mar 2021 | $-0.10 | $-0.13 | -34.02% |
| Mar 1, 2021 | Dec 2020 | $-0.46 | $-2.95 | -547.21% |
| Dec 2, 2020 | Sep 2020 | - | $-0.02 | - |
| Sep 30, 2020 | Jun 2020 | - | $0.30 | - |
| Jun 30, 2020 | Mar 2020 | - | $-0.27 | - |
| Mar 31, 2020 | Dec 2019 | - | $-0.27 | - |
| Sep 30, 2019 | Jun 2019 | - | $-1.21 | - |
| Jun 30, 2019 | Mar 2019 | - | $-2.76 | - |
| Mar 31, 2019 | Dec 2018 | - | $-2.76 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $0.00 | $-2.94 | - |
| Mar 31, 2020 | Dec 2019 | - | $-4.23 | - |
| Mar 31, 2019 | Dec 2018 | - | $-2.76 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 11, 2021 | Jun 2021 | $412.47M | $412.47M | 1.00% |
| May 17, 2021 | Mar 2021 | $200.32M | $200.32M | 1.00% |
| Mar 1, 2021 | Dec 2020 | $166.23M | $166.23M | 1.00% |
| Dec 2, 2020 | Sep 2020 | - | - | - |
| Sep 30, 2020 | Jun 2020 | - | $172.08M | - |
| Jun 30, 2020 | Mar 2020 | - | $165.50M | - |
| Mar 31, 2020 | Dec 2019 | - | - | - |
| Sep 30, 2019 | Jun 2019 | - | - | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $672.89M | $672.89M | 0.00% |
| Mar 31, 2020 | Dec 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
CLOV's next estimated earnings date (based on same quarter last year's report date) is Dec 2, 2021 for the fiscal quarter ending Sep 30, 2021.
Clover Health Investments's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.
CLOV's earnings per share (EPS) was $-0.78, missing the consensus analysts forecast of $-0.14 by -472.69%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 500.00%, and lower than the same period a year before (Jun 2020) by -362.80%.
Revenues were $412.47M, better than the forecast of $412.47M by 0.00%, up by 105.90% from the previous quarter , and up by 139.70% from the same period last year.
The company reported a net income of $-317.61M.Free cash flow for the quarter was $-64.35M , compared to $-92.97M last quarter and $13.01M a year before.
CLOV ended the quarter with $29.14M in total debt, a decrease of -47.92% compared to the previous quarter.
Clover Health Investments's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.
CLOV's earnings per share (EPS) was $-2.94, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2019) by -30.48%.
Revenues were $672.89M, better than the forecast of $672.89M by 0.00%.
The company reported a net income of $-6.74M.
Clover Health Investments reported a free cash flow of $-2.23M for its fiscal year.
The company ended the fiscal year with $806.21K in total debt. lala
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
